Privia Health Group, Inc.
PRVANasdaq
$26.90
↓ -1.2%Jul 17 close · end-of-day
Price
1Y↑ +30.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$3.5B
Enterprise Value
$3.1B
P/E
158.2
P/S
1.6
P/B
4.7
EV/EBITDA
65.0
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$2.2B
Net Income (TTM)
$21.8M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
1.6%
Net Margin
1.0%
ROE
2.9%
ROIC
6.6%
Debt / Equity
—
Net Cash
$419.5M
Return 1Y
+29.9%
Company profile
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices. It offers technology and population health tools to enhance independent providers' workflows.
- CEO
- Matthew S. Morris
- Sector
- Services
- Industry
- Healthcare
- Employees
- 810
- Headquarters
- Virginia
- Website
- priviahealth.com
Management & directors
- Mountcastle DavidEVP & Chief Financial Officer
- Mehrotra ParthChief Executive Officer
- Fargis Edward CEVP & General Counsel
Roles derived from SEC Form 4 filings.
Earnings
PRVA Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$603.8M↑ +25.8%
Diluted EPS$0.02↓ -33.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $817.1M | $966.2M | $1.4B | $1.7B | $1.7B | $2.1B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $25.4M | -$217.4M | -$19.1M | $20.6M | $17.0M | $34.2M |
| Net income | $31.2M | -$188.2M | -$8.6M | $23.1M | $14.4M | $22.9M |
| Diluted EPS | $0.33 | -$1.83 | -$0.08 | $0.19 | $0.11 | $0.18 |
| Operating cash flow | $38.9M | $55.1M | $47.2M | $80.8M | $109.3M | $163.4M |
| Free cash flow | $38.5M | $54.5M | $47.1M | $80.7M | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 3.1% | -22.5% | -1.4% | 1.2% | 1.0% | 1.6% |
| Net margin | 3.8% | -19.5% | -0.6% | 1.4% | 0.8% | 1.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $422.3M | $437.9M | $460.9M | $480.1M | $521.2M | $580.4M | $541.2M | $603.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $5.1M | $5.8M | $5.2M | $5.2M | $3.3M | $14.4M | $11.3M | $7.4M |
| Net income | $3.5M | $3.5M | $4.4M | $4.2M | $2.7M | $6.9M | $9.2M | $3.1M |
| Diluted EPS | $0.03 | $0.03 | $0.03 | $0.03 | $0.02 | $0.05 | $0.08 | $0.02 |
| Operating cash flow | $34.5M | $33.2M | $74.8M | -$24.1M | $8.0M | $52.0M | $127.5M | -$49.5M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 1.2% | 1.3% | 1.1% | 1.1% | 0.6% | 2.5% | 2.1% | 1.2% |
| Net margin | 0.8% | 0.8% | 1.0% | 0.9% | 0.5% | 1.2% | 1.7% | 0.5% |
Company news
Jul 7, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-09 | Mountcastle David· EVP & Chief Financial Officer | Sale | 21,275 | $27.67 | $588,679.25 | filing |
| 2026-07-07 | Mountcastle David· EVP & Chief Financial Officer | Sale | 600 | $27.57 | $16,542.00 | filing |
| 2026-07-06 | Morris Matthew Shawn | Sale | 53,722 | $27.24 | $1.5M | filing |
| 2026-07-06 | Morris Matthew Shawn | Option exercise | 53,722 | $2.00 | $107,444.00 | filing |
| 2026-07-02 | Morris Matthew Shawn | Sale | 59,037 | $27.33 | $1.6M | filing |
| 2026-07-02 | Mountcastle David· EVP & Chief Financial Officer | Sale | 24,734 | $27.50 | $680,185.00 | filing |
| 2026-07-02 | Morris Matthew Shawn | Option exercise | 59,037 | $2.00 | $118,074.00 | filing |
| 2026-07-01 | Morris Matthew Shawn | Sale | 45,634 | $26.52 | $1.2M | filing |
| 2026-07-01 | Morris Matthew Shawn | Sale | 37,041 | $26.93 | $997,514.13 | filing |
| 2026-07-01 | Morris Matthew Shawn | Option exercise | 82,675 | $2.00 | $165,350.00 | filing |
| 2026-06-30 | Morris Matthew Shawn | Sale | 52,823 | $25.72 | $1.4M | filing |
| 2026-06-30 | Morris Matthew Shawn | Option exercise | 52,823 | $2.00 | $105,646.00 | filing |
| 2026-06-29 | Morris Matthew Shawn | Sale | 63,212 | $25.33 | $1.6M | filing |
| 2026-06-29 | Morris Matthew Shawn | Option exercise | 63,212 | $2.00 | $126,424.00 | filing |
| 2026-06-26 | Morris Matthew Shawn | Sale | 88,110 | $25.33 | $2.2M | filing |
| 2026-06-26 | Mountcastle David· EVP & Chief Financial Officer | Sale | 17,196 | $25.18 | $432,995.28 | filing |
| 2026-06-26 | Morris Matthew Shawn | Option exercise | 88,110 | $2.00 | $176,220.00 | filing |
| 2026-06-26 | Mountcastle David· EVP & Chief Financial Officer | Option exercise | 17,196 | $2.00 | $34,392.00 | filing |
| 2026-05-20 | McCarthy Thomas A | Award | 8,463 | $0.00 | $0.00 | filing |
| 2026-05-20 | Morris Matthew Shawn | Award | 8,463 | $0.00 | $0.00 | filing |
| 2026-05-20 | Ryu Jaewon | Award | 8,463 | $0.00 | $0.00 | filing |
| 2026-05-20 | KING DAVID P | Award | 8,463 | $0.00 | $0.00 | filing |
| 2026-05-20 | SOISTMAN FRANCIS S JR | Award | 8,463 | $0.00 | $0.00 | filing |
| 2026-05-20 | BERBERIAN LANCE | Award | 8,463 | $0.00 | $0.00 | filing |
| 2026-05-20 | COCOZZA NANCY G | Award | 8,463 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.